Related Experiment Video
Updated: Jul 13, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Revascularization in heart failure: the role of percutaneous coronary intervention
Ajay J Kirtane1, Jeffrey W Moses
1Columbia University Medical Center, New York, NY 10032, USA.
Insights
Revascularization for ischemic heart failure offers benefits despite risks. Advances in percutaneous coronary intervention (PCI) may improve outcomes for high-risk patients with reduced ejection fraction.
Area of Science:
- Cardiology
- Interventional Cardiology
- Heart Failure Research
Background:
- Revascularization in ischemic heart failure is complex but beneficial.
- Coronary artery bypass grafting (CABG) historically showed superiority over percutaneous coronary intervention (PCI) in patients with reduced ejection fraction.
- Previous studies predated modern PCI advancements like drug-eluting stents and novel support devices.
Purpose of the Study:
- To evaluate the evolving role of PCI in patients with heart failure of ischemic origin.
- To assess the impact of contemporary PCI techniques on clinical outcomes in this high-risk group.
- To explore how new cardiac support devices might mitigate risks associated with PCI in patients with depressed ejection fraction.
Main Methods:
- Review of existing literature comparing CABG and PCI in ischemic heart failure.
- Analysis of outcomes data considering the era of balloon angioplasty versus modern drug-eluting stent technology.
- Consideration of the potential impact of novel cardiac support devices, including intra-aortic balloon pumps.
Main Results:
- While CABG showed benefits, older studies may not reflect current PCI efficacy.
- Drug-eluting stents have significantly reduced repeat revascularization rates after PCI.
- Emerging cardiac support technologies may lower periprocedural complications for high-risk PCI candidates.
Conclusions:
- Revascularization remains crucial for managing ischemic heart failure.
- Contemporary PCI, enhanced by drug-eluting stents and support devices, presents a potentially safer and effective alternative for select high-risk patients.
- Further research is warranted to define the optimal revascularization strategy in the current therapeutic landscape.
Abstract:
Despite being technically challenging and carrying a higher periprocedural risk, the performance of revascularization in patients who have heart failure of ischemic origin can provide substantial clinical benefits. Although several studies have demonstrated a benefit of the performance of coronary artery bypass grafting over percutaneous coronary intervention (PCI) among patients who have depressed ejection fraction undergoing revascularization, most of these studies were conducted during the balloon angioplasty era and before the widespread use of drug-eluting stents that have dramatically reduced the need for repeat revascularization among patients undergoing PCI. The use of lower profile intra-aortic balloon catheters and other novel cardiac support devices may extend the use of PCI and lower rates of periprocedural complications among this high-risk population.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Pericarditis III: Medical Management
Cardiomyopathy V: Interprofessional Care
